These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33773357)

  • 21. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
    Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modular cognitive-behavioral therapy for body dysmorphic disorder: a randomized controlled trial.
    Wilhelm S; Phillips KA; Didie E; Buhlmann U; Greenberg JL; Fama JM; Keshaviah A; Steketee G
    Behav Ther; 2014 May; 45(3):314-27. PubMed ID: 24680228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early response to cognitive behavioral therapy for body dysmorphic disorder as a predictor of outcomes.
    Greenberg JL; Jacobson NC; Hoeppner SS; Bernstein EE; Snorrason I; Schwartzberg A; Steketee G; Phillips KA; Wilhelm S
    J Psychiatr Res; 2022 Aug; 152():7-13. PubMed ID: 35700586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telephone-Administered Cognitive Behavioral Therapy for Body Dysmorphic Disorder: Case Series.
    Drüge M; Roth T; Watzke B
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Body dysmorphic disorder: clinical aspects, nosological dimensions and controversies with anorexia nervosa].
    Behar R; Arancibia M; Heitzer C; Meza N
    Rev Med Chil; 2016 May; 144(5):626-33. PubMed ID: 27552014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Outcomes of Cognitive-Behavioral Therapy for Adolescent Body Dysmorphic Disorder.
    Krebs G; Fernández de la Cruz L; Monzani B; Bowyer L; Anson M; Cadman J; Heyman I; Turner C; Veale D; Mataix-Cols D
    Behav Ther; 2017 Jul; 48(4):462-473. PubMed ID: 28577583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatments.
    Dong N; Nezgovorova V; Hong K; Hollander E
    Expert Opin Pharmacother; 2019 Jul; 20(10):1211-1219. PubMed ID: 31038370
    [No Abstract]   [Full Text] [Related]  

  • 28. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
    Curry J; Rohde P; Simons A; Silva S; Vitiello B; Kratochvil C; Reinecke M; Feeny N; Wells K; Pathak S; Weller E; Rosenberg D; Kennard B; Robins M; Ginsburg G; March J;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1427-39. PubMed ID: 17135988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body Dysmorphic Disorder in Women.
    Phillips KA; Susser LC
    Psychiatr Clin North Am; 2023 Sep; 46(3):505-525. PubMed ID: 37500247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
    Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
    Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Pilot Randomized Controlled Trial of Cognitive-Behavioral Therapy for Adolescents With Body Dysmorphic Disorder.
    Mataix-Cols D; Fernández de la Cruz L; Isomura K; Anson M; Turner C; Monzani B; Cadman J; Bowyer L; Heyman I; Veale D; Krebs G
    J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):895-904. PubMed ID: 26506580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
    Asarnow JR; Emslie G; Clarke G; Wagner KD; Spirito A; Vitiello B; Iyengar S; Shamseddeen W; Ritz L; Birmaher B; Ryan N; Kennard B; Mayes T; DeBar L; McCracken J; Strober M; Suddath R; Leonard H; Porta G; Keller M; Brent D
    J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome.
    Wilhelm S; Berman N; Small BJ; Porth R; Storch EA; Geller D
    J Affect Disord; 2018 Dec; 241():454-460. PubMed ID: 30149332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions.
    Phillips KA; Rogers J
    Child Adolesc Psychiatr Clin N Am; 2011 Apr; 20(2):287-304. PubMed ID: 21440856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of treatment response in pediatric obsessive-compulsive disorder.
    Ginsburg GS; Kingery JN; Drake KL; Grados MA
    J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):868-78. PubMed ID: 18596553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of remission from body dysmorphic disorder after internet-delivered cognitive behavior therapy: a machine learning approach.
    Flygare O; Enander J; Andersson E; Ljótsson B; Ivanov VZ; Mataix-Cols D; Rück C
    BMC Psychiatry; 2020 May; 20(1):247. PubMed ID: 32429939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rates of remission, sustained remission, and recurrence in a randomized controlled trial of cognitive behavioral therapy versus supportive psychotherapy for body dysmorphic disorder.
    Weingarden H; Hoeppner SS; Snorrason I; Greenberg JL; Phillips KA; Wilhelm S
    Depress Anxiety; 2021 Mar; ():. PubMed ID: 33724643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body Dysmorphic Disorder.
    Jassi A; Krebs G
    Psychiatr Clin North Am; 2023 Mar; 46(1):197-209. PubMed ID: 36740353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body dysmorphic disorder: beyond skin deep.
    Husain Z; Janniger EJ; Krysicka JA; Micali G; Schwartz RA
    G Ital Dermatol Venereol; 2014 Aug; 149(4):447-52. PubMed ID: 25068234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Body dysmorphic disorder: Symptoms, prevalence, assessment and treatment].
    Hardardottir H; Hauksdottir A; Bjornsson AS
    Laeknabladid; 2019 Mar; 105(3):125-131. PubMed ID: 30806630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.